Abstract
Postpartum hemorrhage (PPH) remains one of the leading causes of maternal mortality worldwide. Epidemiologic studies have shown a worldwide increase in PPH, extending to developed countries including the United States (US). Although the overall prevalence is low, the rate of PPH in the US has increased from 1.5% in 1999 to 4.1% in 2009 [1]. Numerous national and international societies have invested a great deal of effort in designing Patient Blood Management (PBM) guidelines in an effort to reduce the overall mortality rate associated with PPH. To date, there is no definitive consensus between the various societies’ PBM recommendations. This chapter will highlight a case of life-threatening PPH, detailing blood component therapy in the setting of massive obstetric bleeding. The discussion will include antepartum risk factors for PPH, severity of bleeding assessment, massive transfusion protocols (MTP), lab-directed product replacement, and the use of antifibrinolytic agents. This case and its accompanying information are intended to support the development of an institutional protocol to aggressively manage PPH to reduce the likelihood of hemorrhage-related morbidity and mortality.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kumar N. Postpartum hemorrhage; a major killer of woman: review of current scenario. Obstet Gynecol Int J. 2016;4(4):00116.
Fleischer A, Merowitz N. Care bundles for management of obstetrical hemorrhage. Semin Perinatol. 2016;40(2):99–108.
Kennedy BB, McMurty Baird S. Collaborative strategies for management of obstetric hemorrhage. Crit Care Nurs Clin N Am. 2017;29(3):315–30.
Lalonde A. FIGO guidelines: prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117(2):108–18.
Dutton RP, Shih D, Edelman BB, et al. Safety of uncrossmatched type-O red cells for resuscitation from hemorrhagic shock. J Trauma. 2005;59(6):1445–9.
Zielinski MD, Johnson PM, Jenkins D, et al. Emergency use of prethawed group A plasma in trauma patients. J Trauma Acute Care Surg. 2013;74(1):69–75.
Shaylor R, Weiniger CF, Austin N, Tzabazis A, Shander A, Goodnough LT, Butwick AJ. National and international guidelines for patient blood management in obstetrics: a qualitative review. Anesth Analg. 2016;124(1):10.1213.
Kacmar RM, Mhyre JM, Scavone BM, Fuller AJ, Toledo P. The use of postpartum hemorrhage protocols in United States academic obstetric anesthesia units. Anesth Analg. 2014;119:906–10.
Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82.
Stafford I, Dildy GA, et al. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol. 2008;199:519.el–7.
Hancock A, Weeks AD, Lavender DT. Is accurate and reliable blood loss estimation the ‘crucial step’ in early detection of postpartum haemorrhage: an integrative review of the literature. BMC Pregnancy Childbirth. 2015;15:230.
Vandromme M, Griffin R, Kerby J, et al. Identifying risk for massive transfusion in the relatively normotensive patient: utility of the prehospital shock index. J Trauma. 2011;70(2):384–90.
Clark S. Obstetric hemorrhage. Semin Perinatol. 2016;40(2):109–11.
Collins P, Abdul-Kadir R, Thachil J, For the Subcommittees on women’s Health Issues in Thrombosis and Haemostasis and on Disseminated Intravascular Coagulation. Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14:205–10.
Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol. 2015;28(3):275–84.
Thomas D, Wee M, Clyburn P, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia. 2010;65(11):1153–61.
CRASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet. 2011;377:1096–101.
WOMAN: reducing maternal deaths with tranexamic acid. Lancet. 2017;389(10084):2081.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Griggs, J. (2018). Component Therapy in Obstetric Hemorrhage. In: Nester, T. (eds) Transfusion Management of the Obstetrical Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-77140-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-77140-3_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77139-7
Online ISBN: 978-3-319-77140-3
eBook Packages: MedicineMedicine (R0)